```html

Feverfew for Migraine – A Comprehensive Medical Guide

Overview

Feverfew (Tanacetum parthenium) is a herbaceous perennial plant that has been used for centuries in traditional medicine to treat fever, inflammation, and, most notably, migraine headaches. When we speak of “feverfew migraine,” we refer to the use of feverfew extracts—typically as dried leaf powder, tablets, or liquid tincture—to prevent or lessen migraine attacks.

Migraine is a common neurological disorder affecting roughly 38 million adults in the United States (≈12% of the population) and up to 15% of adolescents worldwide. Women are three times more likely than men to suffer from migraine, especially during reproductive years.

Feverfew is not a cure for migraine, but many patients use it as a complementary, “natural” preventive therapy. Clinical trials have produced mixed results; however, systematic reviews suggest modest benefit for a subset of patients who experience frequent attacks and have not responded well to conventional medications.

Symptoms

The symptoms listed below describe a typical migraine attack, not feverfew side‑effects. Recognising these helps you decide whether feverfew might be appropriate for your pattern of headaches.

• Pulsating or throbbing pain – usually unilateral (one side of the head), though it can become bilateral.
• Moderate to severe intensity – often rated 7–10/10 on a pain scale.
• Photophobia – heightened sensitivity to light.
• Phonophobia – heightened sensitivity to sound.
• Nausea and/or vomiting – common during the headache phase.
• Aura – visual disturbances (flashing lights, zig‑zag lines) or sensory changes that precede the pain in ~20% of sufferers.
• Fatigue or “migraine hangover” – lingering tiredness or difficulty concentrating after the pain resolves.
• Neck stiffness or tenderness – may accompany the headache, especially with tension‑type overlap.
• Triggers – stress, hormonal fluctuations, certain foods, lack of sleep, and environmental changes can precipitate attacks.

Causes and Risk Factors

Feverfew does not cause migraine; rather, it is used to modify the underlying neurovascular processes that generate migraine attacks. Understanding the disease’s pathophysiology clarifies why feverfew may help.

Pathophysiology of Migraine

• Trigeminovascular activation – the trigeminal nerve releases neuropeptides (e.g., CGRP) that dilate meningeal blood vessels, causing pain.
• Cortical spreading depression – a wave of neuronal depolarisation that can trigger aura and inflammatory cascades.
• Serotonin (5‑HT) dysregulation – fluctuations in serotonin levels affect vascular tone and pain pathways.
• Genetic predisposition – mutations in genes such as CACNA1A and ATP1A2 increase susceptibility.

Risk Factors for Migraine (and thus for seeking feverfew therapy)

• Female sex, especially during reproductive years.
• Family history of migraine (first‑degree relative).
• Hormonal changes (menstruation, pregnancy, oral contraceptives).
• Stress, anxiety, or depression.
• Sleep disturbances (both excess and deficit).
• Dietary triggers (aged cheese, chocolate, caffeine, MSG, alcohol).
• Environmental triggers (bright light, strong odors, weather changes).

Diagnosis

Diagnosing migraine is primarily clinical, based on a detailed history and symptom pattern. Feverfew is considered only after a clear migraine diagnosis.

Diagnostic Criteria (International Headache Society – IHS)

1. At least five attacks fulfilling criteria.
2. Headache lasting 4–72 hours (untreated or unsuccessfully treated).
3. At least two of the following characteristics:
   • Unilateral location
   • Pulsating quality
   • Moderate or severe intensity
   • Aggravation by routine physical activity
4. During headache, at least one of:
   • Aura
   • Nausea and/or vomiting
   • Photophobia and phonophobia

When Additional Tests Are Needed

• Neuroimaging (MRI or CT) – ordered if atypical features appear (e.g., sudden onset, neurological deficits) to exclude secondary causes such as tumor or aneurysm.
• Blood work – may be done to rule out infection, anemia, or metabolic disturbances.
• Headache diary – helps establish frequency, triggers, and response to therapies including feverfew.

Treatment Options

Therapy for migraine is divided into acute (abort attacks) and preventive (reduce frequency/intensity). Feverfew belongs to the preventive category.

Feverfew – How It Works

• Parthenolide is the active sesquiterpene lactone thought to inhibit the release of inflammatory mediators (e.g., prostaglandins, serotonin, CGRP).
• It may also modulate platelet aggregation, reducing the “clotting” cascade that can trigger vascular changes.
• Standardized extracts typically contain 0.2–0.4% parthenolide; dosing in clinical trials ranges from 50 mg to 150 mg daily.

Evidence Summary

Systematic reviews (e.g., Cochrane 2020) found that feverfew reduced migraine frequency by an average of 0.5–1.5 attacks per month compared with placebo, with a Number Needed to Treat (NNT) of ~8 for a ≥50% reduction in attacks. Benefit appears greatest in patients with 4–6 attacks/month and those who have not yet tried conventional preventives.

How to Use Feverfew Safely

1. Start low, go slow – 50 mg (one standardized tablet) once daily for two weeks.
2. If tolerated, increase to 100–150 mg daily, split into two doses.
3. Continue for at least 8–12 weeks before assessing efficacy.
4. Buy products that guarantee a minimum parthenolide content (e.g., 0.2%). Look for GMP‑certified manufacturers.

Potential Side‑Effects

• Gastrointestinal upset (bloating, nausea)
• Mouth ulcers or irritation
• Allergic skin reactions (rare)
• Increased bleeding risk – caution with anticoagulants (warfarin, clopidogrel) or NSAIDs.

Other Preventive Medications

• Beta‑blockers (propranolol, metoprolol)
• Anticonvulsants (topiramate, valproate)
• Tricyclic antidepressants (amitriptyline)
• CGRP monoclonal antibodies (erenumab, fremanezumab) – FDA‑approved for chronic migraine.

Acute Treatments

• NSAIDs (ibuprofen, naproxen)
• Triptans (sumatriptan, rizatriptan) – most effective for moderate‑to‑severe attacks.
• Anti‑nausea agents (metoclopramide, prochlorperazine)

Non‑Pharmacologic Procedures

• Neuromodulation – single‑pulse transcranial magnetic stimulation (sTMS) devices.
• Botulinum toxin A – indicated for chronic migraine (≥15 headache days/month).
• Cognitive‑behavioral therapy (CBT) – reduces stress‑related trigger frequency.

Lifestyle Modifications

Even when using feverfew, addressing triggers, sleep hygiene, hydration, and regular exercise markedly improves outcomes.

Living with Feverfew Migraine

Creating a Migraine‑Friendly Routine

• Track triggers – use a smartphone app or paper diary to note foods, mood, sleep, weather, and medication timing.
• Consistent dosing – take feverfew at the same time each day (e.g., with breakfast) to maintain steady blood levels.
• Hydration – aim for 2–3 L of water daily; dehydration is a common trigger.
• Regular meals – avoid skipping meals; low blood glucose can precipitate attacks.
• Sleep hygiene – 7–9 hours/night, same bedtime, limit screens 1 hour before sleep.
• Stress management – daily relaxation (deep breathing, progressive muscle relaxation, short walks).

When to Adjust Feverfew

• If you experience more than 2 additional migraine days per month after 12 weeks at the target dose, discuss dose escalation or alternative preventives with your clinician.
• Any new oral bleeding, easy bruising, or prolonged nosebleeds → stop feverfew and seek medical advice.
• Pregnant or breastfeeding women should avoid feverfew unless a provider specifically recommends it.

Integrating Feverfew with Conventional Care

Never replace a prescribed triptan or preventive drug with feverfew without a clinician’s guidance. Many neurologists use feverfew as an adjunct, especially for patients wishing to minimise pharmaceutical load.

Prevention

General Migraine Prevention Strategies

1. Identify and avoid personal triggers – common culprits include aged cheese, red wine, caffeine excess, and strong odors.
2. Maintain consistent routine – regular sleep, meals, and exercise reduce hypothalamic instability.
3. Stay active – moderate aerobic exercise (30 min, 3–5 times/week) improves vascular health.
4. Limit medication overuse – using acute meds >10 days/month can lead to rebound headache.
5. Consider vitamin & mineral supplementation – magnesium (400–600 mg nightly) and riboflavin (400 mg daily) have modest evidence for prophylaxis.

Specific Role of Feverfew in Prevention

• Best for patients with 4–10 migraine days per month who prefer a botanical approach.
• May be combined with magnesium or riboflavin for additive effect.
• Usually safe for long‑term use (studies up to 12 months) when standardized extracts are used.

Complications

If migraine is inadequately controlled, several complications can arise:

• Medication‑overuse headache (MOH) – chronic daily headache resulting from frequent use of analgesics.
• Reduced productivity – up to 13% of US workers miss at least one day per month due to migraine (CDC).
• Psychiatric comorbidities – higher rates of anxiety and depression; untreated migraine doubles the risk of suicidal ideation.
• Chronic migraine – progression from episodic to chronic migraine (>15 headache days/month) in ~2–3% of sufferers each year.
• Impaired quality of life – measured by HIT‑6 or MIDAS scores; severe migraine can limit social, academic, and occupational functioning.

When to Seek Emergency Care

---

References (accessed May 2026):

• Mayo Clinic. “Migraine.” https://www.mayoclinic.org
• CDC. “Headache and Migraine Statistics.” https://www.cdc.gov
• World Health Organization. “Headache Disorders.” https://www.who.int
• Cochrane Database of Systematic Reviews. “Feverfew for Migraine Prevention.” 2020; CD009638.
• American Headache Society. “Guidelines for Controlled Trials of Acute Treatment of Migraine.” 2022.
• National Institutes of Health (NIH). “Magnesium and Migraine.” 2021.

```